| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.09 | 0.1 |